المؤلفون: Paudel SN; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Hutzen BJ; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Miller KE; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Garfinkle EAR; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Chen CY; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Wang PY; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Glaspell AM; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Currier MA; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Ringwalt EM; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Boon L; JJP Biologics, Warsaw, Poland., Mardis ER; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Cairo MS; Department of Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology, New York Medical College, Valhalla, NY, United States., Ratner N; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Dodd RD; Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Cassady KA; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Cripe TP; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States.; Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 09; Vol. 15, pp. 1456897. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).

نوع المنشور: Journal Article; Published Erratum

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Oncolytic Virotherapy*/methods , Disease Models, Animal*, Animals ; Mice ; Immunotherapy/methods ; Humans ; Oncolytic Viruses/immunology ; Oncolytic Viruses/genetics ; Combined Modality Therapy

المؤلفون: Paudel SN; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Hutzen BJ; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Miller KE; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Garfinkle EAR; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Chen CY; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Wang PY; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Glaspell AM; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Currier MA; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Ringwalt EM; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States., Boon L; JJP Biologics, Warsaw, Poland., Mardis ER; Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Cairo MS; Department of Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology, New York Medical College, Valhalla, NY, United States., Ratner N; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Dodd RD; Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Cassady KA; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States., Cripe TP; Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.; Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States.; Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 25; Vol. 15, pp. 1384623. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Oncolytic Virotherapy*/methods , Tumor Microenvironment*/immunology , Disease Models, Animal*, Animals ; Mice ; Oncolytic Viruses/immunology ; Oncolytic Viruses/genetics ; Cell Line, Tumor ; Immunotherapy/methods ; Humans ; Combined Modality Therapy ; Female ; Mice, Inbred C57BL ; Nerve Sheath Neoplasms/therapy ; Nerve Sheath Neoplasms/immunology ; Nerve Sheath Neoplasms/genetics ; Aminopyridines ; Pyrroles

المؤلفون: Harriss LJA; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Stevens L; Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rayner CJ; Section of Oncology, Department of Clinical & Experimental Medicine, FHMS, University of Surrey, Guildford, UK., Simpson G; Section of Oncology, Department of Clinical & Experimental Medicine, FHMS, University of Surrey, Guildford, UK., Annels NE; Section of Oncology, Department of Clinical & Experimental Medicine, FHMS, University of Surrey, Guildford, UK., Frampton AE; Section of Oncology, Department of Clinical & Experimental Medicine, FHMS, University of Surrey, Guildford, UK.; Hepato-Pancreato-Biliary (HPB) Surgical Unit, Royal Surrey NHS Foundation Trust, Guildford, UK.

المصدر: Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2024 Jun; Vol. 18 (6), pp. 223-226. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278199 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4132 (Electronic) Linking ISSN: 17474124 NLM ISO Abbreviation: Expert Rev Gastroenterol Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Pancreatic Ductal*/therapy , Carcinoma, Pancreatic Ductal*/immunology , Carcinoma, Pancreatic Ductal*/genetics , Pancreatic Neoplasms*/therapy , Pancreatic Neoplasms*/immunology , Oncolytic Virotherapy* , Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , Immunotherapy*/methods, Humans ; Animals ; Adenoviridae/genetics ; Oncolytic Viruses/genetics ; Oncolytic Viruses/immunology ; Immune Checkpoint Inhibitors/therapeutic use ; Immunogenic Cell Death ; Tumor Microenvironment ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism

المؤلفون: Shen Y; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China., Zhao X; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China., Chen L; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China., Wang X; Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China., Wang D; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China., Zhang H; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China., Zheng Z; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China., Huang W; Department of Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China., Zheng C; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada., Chen Y; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Electronic address: chenyu1980@fjmu.edu.cn., Chen C; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Electronic address: ccb@fjmu.edu.cn., Chen Q; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, China. Electronic address: chenqi@fjnu.edu.cn.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 Aug; Vol. 274 (Pt 2), pp. 133297. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: eIF-2 Kinase*/metabolism , eIF-2 Kinase*/genetics , Herpesvirus 1, Human*/genetics , Interferon-beta*/genetics , Interferon-beta*/metabolism , Oncolytic Viruses*/genetics, Animals ; Humans ; Mice ; Cell Line, Tumor ; Neoplasms/therapy ; Neoplasms/immunology ; Neoplasms/genetics ; Oncolytic Virotherapy/methods ; Virus Replication

المؤلفون: Lombardo MS; Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany., Armando F; Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.; Pathology Unit, Veterinary Medicine Department, University of Parma, 43126 Parma, Italy., Marek K; Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany., Rohn K; Institute for Biometry, Epidemiology and Information Processing, University of Veterinary Medicine Hannover, 30559 Hannover, Germany., Baumgärtner W; Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany., Puff C; Department of Pathology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 30; Vol. 25 (15). Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Distemper Virus, Canine*/pathogenicity , Distemper Virus, Canine*/genetics , Histiocytic Sarcoma*/virology , Oncolytic Virotherapy*/methods, Animals ; Dogs ; Mice ; Cell Line, Tumor ; Distemper/virology ; Oncolytic Viruses/genetics ; Oncolytic Viruses/physiology

المؤلفون: Azar F; Transgene SA, Illkirch-Graffenstaden, France., Deforges J; Transgene SA, Illkirch-Graffenstaden, France., Demeusoit C; Transgene SA, Illkirch-Graffenstaden, France., Kleinpeter P; Transgene SA, Illkirch-Graffenstaden, France., Remy C; Transgene SA, Illkirch-Graffenstaden, France., Silvestre N; Transgene SA, Illkirch-Graffenstaden, France., Foloppe J; Transgene SA, Illkirch-Graffenstaden, France., Fend L; Transgene SA, Illkirch-Graffenstaden, France., Spring-Giusti C; Transgene SA, Illkirch-Graffenstaden, France., Quéméneur E; Transgene SA, Illkirch-Graffenstaden, France., Marchand JB; Transgene SA, Illkirch-Graffenstaden, France jem@transgene.fr.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment* , Interleukin-12* , Vaccinia virus*/genetics , CTLA-4 Antigen*/antagonists & inhibitors , Oncolytic Viruses*/immunology, Animals ; Mice ; Humans ; Female ; Macaca fascicularis ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Cell Line, Tumor ; Oncolytic Virotherapy/methods ; Neoplasms/therapy ; Neoplasms/immunology

المؤلفون: Qian X; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China., Ning W; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China., Dunmall LC; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Qu Y; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China., Wang Y; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Zhang H; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 24; Vol. 15, pp. 1427554. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).

نوع المنشور: Case Reports; Review; Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Oncolytic Virotherapy*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Brain Neoplasms*/therapy , Adenoviridae*/genetics, Humans ; Male ; Middle Aged ; Oncolytic Viruses/genetics ; B7-H1 Antigen/antagonists & inhibitors ; Neoplasms, Muscle Tissue/therapy ; Combined Modality Therapy ; Treatment Outcome

المؤلفون: Conley A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Larson C; EpicentRx Inc, La Jolla, USA., Oronsky B; EpicentRx Inc, La Jolla, California, USA boronsky@epicentrx.com., Stirn M; EpicentRx Inc, La Jolla, California, USA., Caroen S; EpicentRx Inc, La Jolla, California, USA., Reid TR; EpicentRx Inc, La Jolla, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 17; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Disease Progression* , Oncolytic Virotherapy*/methods, Humans ; Oncolytic Viruses ; Neoplasms/drug therapy ; Neoplasms/immunology ; Neoplasms/therapy ; Adenoviridae

المؤلفون: Shao L; Cancer Virology Program, Pittsburgh, Pennsylvania.; Department of Microbiology and Molecular Genetics, Pittsburgh, Pennsylvania., Srivastava R; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Delgoffe GM; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Tumor Microenvironment Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania., Thorne SH; Cancer Virology Program, Pittsburgh, Pennsylvania.; KaliVir Immunotherapeutics, Inc., Pittsburgh, Pennsylvania., Sarkar SN; Cancer Virology Program, Pittsburgh, Pennsylvania.; Department of Microbiology and Molecular Genetics, Pittsburgh, Pennsylvania.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

المصدر: Cancer immunology research [Cancer Immunol Res] 2024 Jun 04; Vol. 12 (6), pp. 779-790.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Interferon Regulatory Factor-2*/metabolism , Interferon Regulatory Factor-2*/genetics , Oncolytic Viruses*/genetics , Oncolytic Viruses*/immunology , Interferon Regulatory Factor-1*/metabolism , Interferon Regulatory Factor-1*/genetics, Animals ; Mice ; Cell Line, Tumor ; Oncolytic Virotherapy/methods ; Humans ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Vaccinia virus/genetics ; Vaccinia virus/immunology ; Mice, Inbred C57BL ; Melanoma, Experimental/immunology ; Melanoma, Experimental/therapy ; Disease Models, Animal ; Female

المؤلفون: de la Nava D; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Ausejo-Mauleon I; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Laspidea V; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Gonzalez-Huarriz M; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Lacalle A; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Casares N; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Zalacain M; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Marrodan L; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., García-Moure M; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Ochoa MC; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Tallon-Cobos AC; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Hernandez-Osuna R; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Marco-Sanz J; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Dhandapani L; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Hervás-Corpión I; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Becher OJ; Jack Martin Fund Division of Pediatric Hematology-oncology, Mount Sinai, New York, USA., Nazarian J; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland.; Virginia Tech University, Washington, District of Columbia, USA.; Children's National Health System, Center for Genetic Medicine Research, Washington, District of Columbia, USA., Mueller S; University of California, San Francisco San Francisco, California, USA.; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hernaez M; Bioinformatics Platform, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Guruceaga E; Bioinformatics Platform, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Koschmann C; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Venneti S; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Allen JE; Chimerix, Inc. Durham, North Carolina, USA., Dun MD; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Fueyo J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gomez-Manzano C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gallego Perez-Larraya J; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Patiño-García A; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Labiano S; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain., Alonso MM; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Solid Tumor Program, Center for the Applied Medical Research, Pamplona, Spain.; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Aug 05; Vol. 26 (8), pp. 1509-1525.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Oncolytic Virotherapy*/methods , Glioma*/therapy , Glioma*/pathology , Glioma*/virology , Brain Neoplasms*/therapy , Brain Neoplasms*/pathology , Brain Neoplasms*/virology , Brain Neoplasms*/drug therapy , Xenograft Model Antitumor Assays*, Animals ; Humans ; Mice ; Tumor Microenvironment ; Adenoviridae/genetics ; Combined Modality Therapy ; Oncolytic Viruses ; Tumor Cells, Cultured ; Child ; Virus Replication